Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) Q1 2026 Earnings

SILO·Reported May 13, 2026·After market close

Silo Pharma, Inc. reported Q1 2026 revenue of $18.0K (+0.0% YoY), beat analyst consensus of $18.0K by $26.0. Diluted EPS came in at $-0.12 (+47.8% YoY), beat the $-0.32 consensus by $0.20.

Revenue
$18.0Kbeat by $26.0
Consensus: $18.0K
Diluted EPS
$-0.12beat by $0.20
Consensus: $-0.32
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001213900-26-056079

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Silo Pharma, Inc.'s Q1 2026 earnings report.

Silo Pharma, Inc. (SILO) reported Q1 2026 earnings on May 13, 2026 after market close.

Silo Pharma, Inc. reported revenue of $18.0K and diluted EPS of $-0.12 for Q1 2026.

Revenue beat the consensus estimate of $18.0K by $26.0. EPS beat the consensus estimate of $-0.32 by $0.20.

Compared to the same quarter a year prior, revenue grew 0.0% from $18.0K a year earlier and diluted EPS grew 47.8% from $-0.23.

You can read the 10-Q periodic report (0001213900-26-056079) directly on SEC EDGAR. The filing index links above go to sec.gov.